Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden ; volume:74 ; number:7 ; day:9 ; month:4 ; year:2018 ; pages:971-978 ; date:7.2018
European journal of clinical pharmacology ; 74, Heft 7 (9.4.2018), 971-978, 7.2018
- Creator
-
Frisk, P.
- Contributor
-
Aggefors, K.
Cars, T.
Feltelius, N.
Loov, S. A.
Wettermark, B.
Weiland, O.
SpringerLink (Online service)
- DOI
-
10.1007/s00228-018-2456-y
- URN
-
urn:nbn:de:101:1-2018082123265125857084
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frisk, P.
- Aggefors, K.
- Cars, T.
- Feltelius, N.
- Loov, S. A.
- Wettermark, B.
- Weiland, O.
- SpringerLink (Online service)
Other Objects (12)
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection